Alnylam Pharmaceuticals Inc (ALNY) Transcripts
Q3 2024 Alnylam Pharmaceuticals Inc Earnings Call Transcript
Oct 31, 2024
$266.59
(-5.29%)
Earnings
Q2 2024 Alnylam Pharmaceuticals Inc Earnings Call Transcript
Aug 01, 2024
$268.61
(+13.12%)
Earnings
Q1 2024 Alnylam Pharmaceuticals Inc Earnings Call Transcript
May 02, 2024
$150.31
(+0.23%)
Earnings
Q4 2023 Alnylam Pharmaceuticals Inc Earnings Call Transcript
Feb 15, 2024
$147.43
(-10.19%)
Earnings
Alnylam Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Jan 08, 2024
Alnylam Pharmaceuticals Inc R&D Day Transcript
Dec 13, 2023
Alnylam Pharmaceuticals Inc at Piper Sandler Healthcare Conference Transcript
Nov 29, 2023
Alnylam Pharmaceuticals Inc at Stifel Healthcare Conference Transcript
Nov 14, 2023
Alnylam Pharmaceuticals Inc at Jefferies London Healthcare Conference Transcript
Nov 14, 2023
Q3 2023 Alnylam Pharmaceuticals Inc Earnings Call Transcript
Nov 02, 2023
$161.53
(+2.89%)
Earnings
Alnylam Pharmaceuticals Inc To Host Investor Call Transcript
Oct 09, 2023
Alnylam Pharmaceuticals Inc at Canaccord Genuity Growth Conference Transcript
Aug 10, 2023
Q2 2023 Alnylam Pharmaceuticals Inc Earnings Call Transcript
Aug 03, 2023
$190.1
(+1.65%)
Earnings
Alnylam Pharmaceuticals Inc to Discuss Collaboration with Roche Transcript
Jul 24, 2023
Alnylam Pharmaceuticals Inc at Goldman Sachs Healthcare Conference Transcript
Jun 12, 2023
Alnylam Pharmaceuticals Inc at Bank of America Global Healthcare Conference Transcript
May 10, 2023
Q1 2023 Alnylam Pharmaceuticals Inc Earnings Call Transcript
May 04, 2023
$205.39
(+2.95%)
Earnings
Alnylam Pharmaceuticals Inc ALN-APP Call Transcript
Apr 26, 2023
Alnylam Pharmaceuticals Inc at Ginkgo Bioworks Ferment Conference Transcript
Apr 19, 2023
Alnylam Pharmaceuticals Inc at Stifel CNS Days (Virtual) Transcript
Mar 29, 2023
Alnylam Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript
Mar 16, 2023
Alnylam Pharmaceuticals Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Mar 15, 2023
Alnylam Pharmaceuticals Inc at Cowen Health Care Conference Transcript
Mar 08, 2023
Q4 2022 Alnylam Pharmaceuticals Inc Earnings Call Transcript
Feb 23, 2023
$196.24
(-2.42%)
Earnings
Alnylam Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Jan 09, 2023
Alnylam Pharmaceuticals Inc R&D Day Transcript
Dec 15, 2022
Alnylam Pharmaceuticals Inc at Piper Sandler Healthcare Conference Transcript
Nov 30, 2022
Alnylam Pharmaceuticals Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript
Nov 29, 2022
Alnylam Pharmaceuticals Inc at Stifel Healthcare Conference Transcript
Nov 16, 2022
Alnylam Pharmaceuticals Inc at Jefferies London Healthcare Conference Transcript
Nov 16, 2022
Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: CNS Delivery and ALN-APP, in Development for the Treatment of Alzheimer's Disease and Cerebral Amyloid Angiopathy Transcript
Nov 01, 2022
Q3 2022 Alnylam Pharmaceuticals Inc Earnings Call Transcript
Oct 27, 2022
$194
(-3.49%)
Earnings
Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Alnylam Engine for Sustainable Innovation: Leadership in RNAi Platform and Human Genetics Transcript
Oct 21, 2022
Alnylam Pharmaceuticals Inc to Discuss APOLLO-B Results at HFSA Scientific Meeting Transcript
Oct 01, 2022
Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Cemdisiran, in Development for the Treatment of IgA Nephropathy (IgAN) and Other Complement-Mediated Diseases Transcript
Sep 27, 2022
Alnylam Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2022
Alnylam Pharmaceuticals Inc to Discuss APOLLO-B Results - Conference Call Transcript
Sep 08, 2022
Alnylam Pharmaceuticals Inc to Discuss APOLLO-B Topline Results Transcript
Aug 03, 2022
Q2 2022 Alnylam Pharmaceuticals Inc Earnings Call Transcript
Jul 28, 2022
$143.52
(+1.09%)
Earnings
Alnylam Pharmaceuticals Inc to Discuss FDA Approval of AMVUTTRA (Vutrisiran) Transcript
Jun 14, 2022
Alnylam Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 13, 2022
Alnylam Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
Jun 09, 2022
Alnylam Pharmaceuticals Inc at UBS Global Healthcare Conference Transcript
May 25, 2022
Alnylam Pharmaceuticals Inc at H C Wainwright Global Investment Conference (Virtual) Transcript
May 24, 2022
Alnylam Pharmaceuticals Inc at Bank of America Healthcare Conference Transcript
May 11, 2022
Q1 2022 Alnylam Pharmaceuticals Inc Earnings Call Transcript
Apr 28, 2022
$143.16
(-7.59%)
Earnings
Alnylam Pharmaceuticals Inc at Stifel CNS Days (Virtual) Transcript
Mar 28, 2022
Alnylam Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript
Mar 15, 2022
Alnylam Pharmaceuticals Inc at Cowen Health Care Conference (Virtual) Transcript
Mar 08, 2022
Alnylam Pharmaceuticals Inc at SVB Leerink Global Healthcare (Virtual) Transcript
Feb 17, 2022
Q4 2021 Alnylam Pharmaceuticals Inc Earnings Call Transcript
Feb 10, 2022
$150.86
(-0.36%)
Earnings
Alnylam Pharmaceuticals Inc to Present HELIOS-A 18-Month Results - Conference Call Transcript
Jan 21, 2022
Alnylam Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 10, 2022
Alnylam Pharmaceuticals Inc at Piper Sandler Healthcare Conference (Virtual) Transcript
Dec 02, 2021
Alnylam Pharmaceuticals Inc at Evercore ISI HealthCONx Virtual Conference Transcript
Nov 30, 2021
Alnylam Pharmaceuticals Inc Virtual R&D Day Transcript
Nov 19, 2021
Q3 2021 Alnylam Pharmaceuticals Inc Earnings Call Transcript
Oct 28, 2021
$162.14
(-15.18%)
Earnings
Alnylam Pharmaceuticals Inc at Chardan Genetic Medicines Conference (Virtual) Transcript
Oct 05, 2021
Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: CNS & Extrahepatic RNAi Pipeline Programs Transcript
Oct 01, 2021
Alnylam Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Sep 28, 2021
Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Liver-Directed RNAi Pipeline Programs Transcript
Sep 20, 2021
Alnylam Pharmaceuticals Inc at Bank of America Global Healthcare Conference (Virtual) Transcript
Sep 16, 2021
Alnylam Pharmaceuticals Inc at H C Wainwright Global Investment Conference (Virtual) Transcript
Sep 13, 2021
Alnylam Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 09, 2021
Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Lumasiran, for the Treatment of Primary Hyperoxaluria Type 1 Transcript
Aug 19, 2021
Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Givosiran, for the Treatment of Acute Hepatic Porphyria Transcript
Aug 04, 2021
Q2 2021 Alnylam Pharmaceuticals Inc Earnings Call Transcript
Aug 03, 2021
$178.81
(+0.48%)
Earnings
Alnylam Pharmaceuticals Inc "RNAi Roundtable" Webcast Series: Patisiran & Vutrisiran, in Development for the Treatment of ATTR Amyloidosis Transcript
Jul 16, 2021
Alnylam Pharmaceuticals Inc "RNAi Roundtable” Webcast Series: ALN-AGT, in Development for the Treatment of Hypertension Transcript
Jun 30, 2021
Alnylam Pharmaceuticals Inc at Nasdaq Investor Conference (Virtual) Transcript
Jun 15, 2021
Alnylam Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 08, 2021
Alnylam Pharmaceuticals Inc at Sanford C Bernstein Strategic Decisions Conference (Virtual) Transcript
Jun 03, 2021
Alnylam Pharmaceuticals Inc at Jefferies Healthcare Conference (Virtual) Transcript
Jun 01, 2021
Alnylam Pharmaceuticals Inc at UBS Global Healthcare Virtual Conference Transcript
May 25, 2021
Alnylam Pharmaceuticals Inc Annual Shareholders Meeting Transcript
May 18, 2021
Alnylam Pharmaceuticals Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 11, 2021
Q1 2021 Alnylam Pharmaceuticals Inc Earnings Call Transcript
Apr 29, 2021
$139.69
(-2.68%)
Earnings
Alnylam Pharmaceuticals Inc to Discuss Full 9-Month Results from the HELIOS-A Phase 3 Study of Vutrisiran - Corporate Call Transcript
Apr 19, 2021
Alnylam Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript
Apr 13, 2021
Alnylam Pharmaceuticals Inc at Stifel CNS Day Transcript
Apr 01, 2021
Alnylam Pharmaceuticals Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Mar 10, 2021
Alnylam Pharmaceuticals Inc at H C Wainwright Global Life Sciences Conference (Virtual) Transcript
Mar 09, 2021
Alnylam Pharmaceuticals Inc at Cowen Healthcare Conference (Virtual) Transcript
Mar 01, 2021
Alnylam Pharmaceuticals Inc at SVB Leerink Global Healthcare Conference (Virtual) Transcript
Feb 25, 2021
Q4 2020 Alnylam Pharmaceuticals Inc Earnings Call Transcript
Feb 11, 2021
$165.38
(+0.74%)
Earnings
Alnylam Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2021
Alnylam Pharmaceuticals Inc to Discuss Topline HELIOS-A Phase 3 Results of Vutrisiran - Conference Call Transcript
Jan 07, 2021
Alnylam Pharmaceuticals Inc R&D Day 2020 (Event 2) Transcript
Dec 16, 2020
Alnylam Pharmaceuticals Inc R&D Day 2020 (Event 1) Transcript
Dec 15, 2020
Alnylam Pharmaceuticals Inc at Nasdaq Virtual Investor Conference Transcript
Dec 04, 2020
Alnylam Pharmaceuticals Inc to Discuss FDA Approval of OXLUMO (Lumasiran) Conference Call Transcript
Nov 24, 2020
Alnylam Pharmaceuticals Inc at Stifel Virtual Healthcare Conference Transcript
Nov 16, 2020
Alnylam Pharmaceuticals Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 09, 2020
Q3 2020 Alnylam Pharmaceuticals Inc Earnings Call Transcript
Nov 05, 2020
$137.86
(-1.17%)
Earnings
Alnylam Pharmaceuticals Inc at H C Wainwright Hepatitis B Virus (HBV) Mini-Conference (Virtual) Transcript
Oct 20, 2020
Alnylam Pharmaceuticals Inc at Chardan Genetic Medicines Conference (Virtual) Transcript
Oct 05, 2020
Alnylam Pharmaceuticals Inc at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) Transcript
Sep 17, 2020
Alnylam Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Sep 16, 2020
Alnylam Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 15, 2020
Alnylam Pharmaceuticals Inc at Citi BioPharma Conference (Virtual) Transcript
Sep 10, 2020
BridgeBio Pharma Inc at Citi BioPharma Conference (Virtual)- Panel: TTR Amyloidosis Transcript
Sep 09, 2020
Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Patisiran & Vutrisiran, in Development for the Treatment of Transthyretin-Mediated Amyloidosis Transcript
Sep 03, 2020
Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Lumasiran, in Development for the Treatment of Primary Hyperoxaluria Type I Transcript
Aug 10, 2020
Q2 2020 Alnylam Pharmaceuticals Inc Earnings Call Transcript
Aug 06, 2020
$144.12
(-4.20%)
Earnings
Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Early Stage RNAi Therapeutics Pipeline Transcript
Jul 17, 2020
Alnylam Pharmaceuticals Inc at Bank of America Merrill Lynch Napa Healthcare Conference (Virtual) Transcript
Jun 24, 2020
Alnylam Pharmaceuticals Inc "RNAi Roundtable” Webcast Series: ALN-AGT, in Development for the Treatment of Hypertension Transcript
Jun 23, 2020
Alnylam Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 11, 2020
Alnylam Pharmaceuticals Inc to Discuss Full Results from ILLUMINATE-A Phase 3 Study of Lumasiran at ERA-EDTA International Congress Transcript
Jun 07, 2020
Alnylam Pharmaceuticals Inc at Jefferies Healthcare Conference (Virtual) Transcript
Jun 02, 2020
Alnylam Pharmaceuticals Inc at UBS Global Healthcare Conference (Virtual) Transcript
May 20, 2020
Alnylam Pharmaceuticals Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
May 14, 2020
Alnylam Pharmaceuticals Inc Annual Shareholders Meeting Transcript
May 06, 2020
Q1 2020 Alnylam Pharmaceuticals Inc Earnings Call Transcript
May 06, 2020
$145.27
(+2.86%)
Earnings
Alnylam Pharmaceuticals Inc at Needham Healthcare Conference Transcript
Apr 14, 2020
Alnylam Pharmaceuticals Inc Conference Call to Discuss Strategic Financing Collaboration with Blackstone Transcript
Apr 13, 2020
Alnylam Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript
Mar 10, 2020
Alnylam Pharmaceuticals Inc at Cowen HealthCare Conference Transcript
Mar 03, 2020
Alnylam Pharmaceuticals Inc at Leerink Global Healthcare Conference Transcript
Feb 27, 2020
Q4 2019 Alnylam Pharmaceuticals Inc Earnings Call Transcript
Feb 06, 2020
$121.96
(+0.30%)
Earnings
Alnylam Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Jan 13, 2020
Alnylam Pharmaceuticals Inc to Discuss Topline Results from ILLUMINATE-A Phase 3 Study of Lumasiran Conference Call Transcript
Dec 17, 2019
Alnylam Pharmaceuticals Inc at Piper Jaffray Healthcare Conference Transcript
Dec 05, 2019
Alnylam Pharmaceuticals Inc at Evercore HealthCONx Conference Transcript
Dec 04, 2019
Alnylam Pharmaceuticals Inc R&D Day 2019 Transcript
Nov 22, 2019
Alnylam Pharmaceuticals Inc Conference Call to Discuss FDA Approval of GIVLAARI (Givosiran) Transcript
Nov 20, 2019
Alnylam Pharmaceuticals Inc at Stifel Healthcare Conference Transcript
Nov 19, 2019
Q3 2019 Alnylam Pharmaceuticals Inc Earnings Call Transcript
Oct 31, 2019
$86.74
(-0.61%)
Earnings
Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Lumasiran, in Development for the Treatment of Primary Hyperoxaluria Type 1 Transcript
Oct 10, 2019
Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: Givosiran, in Development for the Treatment of Acute Hepatic Porphyria Transcript
Oct 07, 2019
Alnylam Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Oct 03, 2019
Alnylam Pharmaceuticals Inc "RNAi Roundtable" Webcast Series: Patisiran & Vutrisiran, for the Treatment of Transthyretin-Mediated Amyloidosis Transcript
Sep 16, 2019
Alnylam Pharmaceuticals Inc at Morgan Stanley Healthcare Conference Transcript
Sep 09, 2019
Q2 2019 Alnylam Pharmaceuticals Inc Earnings Call Transcript
Aug 06, 2019
$74.38
(+4.16%)
Earnings
Alnylam Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 12, 2019
Alnylam Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
Jun 07, 2019
Alnylam Pharmaceuticals Inc at Bank of America Merrill Lynch Health Care Conference Transcript
May 16, 2019
Q1 2019 Alnylam Pharmaceuticals Inc Earnings Call Transcript
May 01, 2019
$83.03
(-7.06%)
Earnings
Alnylam Pharmaceuticals Inc Annual Shareholders Meeting Transcript
Apr 25, 2019
Alnylam Pharmaceuticals Inc to Present Givosiran Phase 3 Data at the European Association for the Study of the Liver (EASL) International Liver Congress Conference Call Transcript
Apr 13, 2019
Alnylam Pharmaceuticals Inc to Discuss Regeneron Collaboration - Call Transcript
Apr 08, 2019
Alnylam Pharmaceuticals Inc at Cowen Health Care Conference Transcript
Mar 13, 2019
Alnylam Pharmaceuticals Inc to Discuss Topline Results from ENVISION Phase 3 Study of Givosiran Conference Call Transcript
Mar 06, 2019
Alnylam Pharmaceuticals Inc at Leerink Partners Global Healthcare Conference Transcript
Feb 27, 2019
Alnylam Pharmaceuticals Inc at Biotechnology Industry Organization (BIO) CEO & Investor Conference Transcript
Feb 11, 2019
Q4 2018 Alnylam Pharmaceuticals Inc Earnings Call Transcript
Feb 07, 2019
$80.8
(-1.17%)
Earnings